Chemours (CC) Other Operating Expenses (2014 - 2026)

Chemours' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 91.67% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was -$63.0 million, a 425.0% decrease from a year earlier, with the FY2025 full-year figure at -$122.0 million, down 246.99% from the prior year.
• Other Operating Expenses advanced to $1.0 million in Q1 2026 per CC's latest filing, from -$29.0 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $72.0 million in Q3 2023 and bottomed at -$148.0 million in Q4 2023.
• The 5-year median for Other Operating Expenses is $1.0 million (2026), against an average of -$23.1 million.
• Across the five-year window, Other Operating Expenses surged 120.0% in 2023 and sank 1550.0% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $5.0 million in 2022, then tumbled by 3060.0% to -$148.0 million in 2023, then soared by 101.35% to $2.0 million in 2024, then sank by 1550.0% to -$29.0 million in 2025, then surged by 103.45% to $1.0 million in 2026.
• Per Business Quant, the three latest CC Other Operating Expenses figures stand at $1.0 million (Q1 2026), -$29.0 million (Q4 2025), and -$35.0 million (Q2 2025).